Unknown

Dataset Information

0

Engineered C-N Lyase: Enantioselective Synthesis of Chiral Synthons for Artificial Dipeptide Sweeteners.


ABSTRACT: Aspartic acid derivatives with branched N-alkyl or N-arylalkyl substituents are valuable precursors to artificial dipeptide sweeteners such as neotame and advantame. The development of a biocatalyst to synthesize these compounds in a single asymmetric step is an as yet unmet challenge. Reported here is an enantioselective biocatalytic synthesis of various difficult N-substituted aspartic acids, including N-(3,3-dimethylbutyl)-l-aspartic acid and N-[3-(3-hydroxy-4-methoxyphenyl)propyl]-l-aspartic acid, precursors to neotame and advantame, respectively, using an engineered variant of ethylenediamine-N,N'-disuccinic acid (EDDS) lyase from Chelativorans sp. BNC1. This engineered C-N lyase (mutant D290M/Y320M) displayed a remarkable 1140-fold increase in activity for the selective hydroamination of fumarate compared to that of the wild-type enzyme. These results present new opportunities to develop practical multienzymatic processes for the more sustainable and step-economic synthesis of an important class of food additives.

SUBMITTER: Zhang J 

PROVIDER: S-EPMC6973171 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Engineered C-N Lyase: Enantioselective Synthesis of Chiral Synthons for Artificial Dipeptide Sweeteners.

Zhang Jielin J   Grandi Eleonora E   Fu Haigen H   Saravanan Thangavelu T   Bothof Laura L   Tepper Pieter G PG   Thunnissen Andy-Mark W H AWH   Poelarends Gerrit J GJ  

Angewandte Chemie (International ed. in English) 20191119 1


Aspartic acid derivatives with branched N-alkyl or N-arylalkyl substituents are valuable precursors to artificial dipeptide sweeteners such as neotame and advantame. The development of a biocatalyst to synthesize these compounds in a single asymmetric step is an as yet unmet challenge. Reported here is an enantioselective biocatalytic synthesis of various difficult N-substituted aspartic acids, including N-(3,3-dimethylbutyl)-l-aspartic acid and N-[3-(3-hydroxy-4-methoxyphenyl)propyl]-l-aspartic  ...[more]

Similar Datasets

| S-EPMC5727103 | biostudies-other
| S-EPMC2575186 | biostudies-literature
| S-EPMC2597475 | biostudies-literature
| S-EPMC9403034 | biostudies-literature
| S-EPMC10181363 | biostudies-literature
| S-EPMC8162767 | biostudies-literature
| S-EPMC3519432 | biostudies-literature
| S-EPMC3306814 | biostudies-literature
| S-EPMC10425721 | biostudies-literature
| PRJEB37701 | ENA